Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 21, Issue 7, pp. 1156-1166
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 24, 2012
- Revision received March 12, 2012
- Accepted March 14, 2012
- Published first March 27, 2012.
Article Versions
- Previous version (March 27, 2012 - 09:40).
- Previous version (June 1, 2012 - 08:15).
- You are viewing the most recent version of this article.
Copyright & Usage
©2012 American Association for Cancer Research.
Author Information
- Celine M. Vachon23,49,
- Christopher G. Scott23,49,
- Peter A. Fasching4,43,
- Per Hall40,58,
- Rulla M. Tamimi28,30,54,
- Jingmei Li40,41,58,
- Jennifer Stone1,42,
- Carmel Apicella1,42,
- Fabrice Odefrey2,42,
- Gretchen L. Gierach36,56,
- Sebastian M. Jud6,43,
- Katharina Heusinger6,43,
- Matthias W. Beckmann6,43,
- Marina Pollan7,8,44,
- Pablo Fernández-Navarro7,8,44,
- Anna Gonzalez-Neira9,10,44,
- Javier Benitez9,10,44,
- Carla H. van Gils11,45,
- Mariëtte Lokate11,45,
- N. Charlotte Onland-Moret11,45,
- Petra H.M. Peeters11,45,
- Judith Brown12,46,59,
- Jean Leyland14,46,59,
- Jajini S. Varghese14,46,59,
- Douglas F. Easton12,46,59,
- Deborah J. Thompson12,46,48,59,
- Robert N. Luben12,46,
- Ruth M.L. Warren14,46,48,
- Nicholas J. Wareham15,46,
- Ruth J.F. Loos15,46,
- Kay-Tee Khaw13,46,
- Giske Ursin5,16,17,47,57,
- Eunjung Lee5,47,
- Simon A. Gayther5,48,
- Susan J. Ramus5,48,
- Rosalind A. Eeles20,48,
- Martin O. Leach19,20,48,
- Gek Kwan-Lim19,20,48,
- Fergus J. Couch24,49,
- Graham G. Giles1,3,50,
- Laura Baglietto1,3,50,
- Kavitha Krishnan3,50,
- Melissa C. Southey2,50,
- Loic Le Marchand25,51,
- Laurence N. Kolonel25,51,
- Christy Woolcott25,51,
- Gertraud Maskarinec25,51,
- Christopher A. Haiman5,51,
- Kate Walker21,52,
- Nichola Johnson22,52,
- Valeria A. McCormack26,52,
- Margarethe Biong18,53,
- Grethe I.G. Alnaes18,53,
- Inger Torhild Gram27,53,
- Vessela N. Kristensen18,53,
- Anne-Lise Børresen-Dale18,53,
- Sara Lindström29,30,54,
- Susan E. Hankinson28,30,54,
- David J. Hunter29,30,54,
- Irene L. Andrulis31,33,55,
- Julia A. Knight32,34,55,
- Norman F. Boyd35,55,
- Jonine D. Figuero36,56,
- Jolanta Lissowska37,56,
- Ewa Wesolowska37,56,
- Beata Peplonska38,57,
- Agnieszka Bukowska38,57,
- Edyta Reszka39,57,
- JianJun Liu41,58,
- Louise Eriksson40,58,
- Kamila Czene40,58,
- Tina Audley12,59,
- Anna H. Wu5,
- V. Shane Pankratz23,49,
- John L. Hopper1,42, and
- Isabel dos-Santos-Silva21,52
- Authors' Affiliations: 1School of Population Health, Centre for Molecular Environmental, Genetic and Analytic Epidemiology, 2Department of Pathology, University of Melbourne; 3Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; 4Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles; 5Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; 6University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany; 7Area de Epidemiologia Ambiental y Cáncer, Centro Nacional de Epidemiologia, Instituto de Salud Carlos III; 8Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiologia y Salud Pública CIBERESP); 9Human Genetics Group, Spanish National Cancer Research Centre (CNIO); 10Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain; 11Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands; 12Department of Public Health and Primary Care, 13MRC Centre for Nutritional Epidemiology in Cancer Prevention and Survival (CNC), 14Department of Radiology, University of Cambridge, Addenbrooke's NHS Foundation Trust; 15MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 16Cancer Registry of Norway; 17Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo; 18Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway; 19CR-UK and EPSRC Cancer Imaging Centre; 20Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London; 21Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine; 22Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom; Departments of 23Health Sciences Research and 24Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; 25University of Hawaii Cancer Center, Honolulu, Hawaii; 26Section of Environment and Radiation, International Agency for Research on Cancer, Lyon, France; 27Institute of Community Medicine, Faculty of Health Sciences, University of Tromso, Tromso, Norway; 28Channing Laboratory, Brigham and Women's Hospital; 29Program in Molecular and Genetic Epidemiology; 30Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 31Fred A. Litwin Center for Cancer Genetics, Samuel Lunenfeld Research Institute, 32Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital; 33Department of Molecular Genetics, 34Dalla Lana School of Public Health, University of Toronto; 35Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Toronto, Ontario, Canada; 36Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 37Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Departments of 38Environmental Epidemiology and 39Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Lodz, Poland; 40Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; 41Human Genetics, Genome Institute of Singapore, Singapore; 42Australian Mammographic Density Twins and Sisters Study (AMDTSS); 43Bavarian Breast Cancer Cases and Controls (BBCC); 44Determinants of Mammographic Density in Spain (DDM-Spain); 45EPIC-NL (Dutch part of European Prospective Investigation into Cancer Nutrition; EPIC-NL); 46European Prospective Investigation into Cancer–Norfolk I and II (EPIC-Norfolk I and II); 47Women's Learning the Influence of Family and Environment Study (LIFE); 48Magnetic Resonance Imaging in Breast Screening (MARIBS); 49Mayo Clinic Breast Cancer Study (MCBCS); 50Melbourne Collaborative Cohort Study (MCCS); 51Multiethnic Cohort Study (MEC); 52Mammography, Oestrogens and Growth Factors Study (MOG); 53Norwegian Breast Cancer Study (NBCS); 54Nurses' Health Study (NHS); 55Ontario Familial Breast Cancer Registry (OFBCR); 56Polish Breast Cancer Study (PBCS); 57Polish Nurses and Midwives Study (PNS); 58Singapore and Sweden Breast Cancer Study (SASBAC); and 59Sisters in Breast Cancer Screening (SIBS)
- Corresponding Authors:
Celine M. Vachon, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905. Phone: 507-284-9977; Fax: 507-266-2478; E-mail: vachon{at}mayo.edu; and Isabel dos-Santos-Silva, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom. Phone: 44-020-7927-2113; Fax: 44-020-7436-4230; E-mail: isabel.silva{at}lshtm.ac.uk
July 2012
Volume 21, Issue 7
Volume 21, Issue 7
Common Breast Cancer Susceptibility Variants in LSP1 and RAD51L1 Are Associated with Mammographic Density Measures that Predict Breast Cancer Risk
Jump to section
Advertisement